Sarep­ta in­di­cates it's safe to con­tin­ue Ele­v­idys dos­ing in Eu­rope; Ep­silo­gen buys TigaTx

Plus, news about Vick­ers Ven­ture Part­ners:

Sarep­ta Ther­a­peu­tics says safe­ty board clears paused Ele­v­idys tri­als: An in­de­pen­dent da­ta mon­i­tor­ing com­mit­tee

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER